Three real-world cases illustrate strategies to identify and manage GA across a range of scenarios, from coexisting wet age-related macular degeneration to functionally monocular patients.
Priya S. Vakharia, MD, FASRS
Advertisement
Retina Vitreous Associates of Florida
Articles by Priya S. Vakharia, MD, FASRS
Vakharia insights from the ARCHER trial on geographic atrophy treatment for dry AMD, highlighting promising results and future directions in ophthalmology.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
Opus Genetics reaches FDA alignment on phase 3 registrational design for OPGx-LCA5 gene therapy
2
FDA grants RMAT designation to Emmecell's EO2002 for corneal endothelial disease
3
Eyes on June 2026: Approvals, pipeline momentum, and AI under the microscope
4
Understanding meibomian gland dysfunction, neuropathic pain, and the evolving dry eye patient
5